ECE1 and End Stage Liver Disease: Patients with fecal samples tested “ECE1-positive” had increased gut permeability, higher MELD (model for end-stage liver disease) score and 90-day mortality compared with “ECE1-negative” patients, suggesting that candidalysin produced in the intestinal lumen could reach the liver via increased intestinal permeability and exert its effects on the liver.